BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:10 PM
 | 
Mar 22, 2010
 |  BC Extra  |  Company News

FDA recommends Rotarix suspension

FDA recommended the temporary suspension of Rotarix from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) as a precautionary measure after components of an extraneous virus were detected in the oral attenuated rotavirus vaccine. According to FDA, an independent U.S. academic research team found DNA from porcine circovirus 1 (PCV1) in Rotarix...

Read the full 227 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >